Net profit of Mankind Pharma rose 7.50% to Rs 408.75 crore in the quarter ended December 2025 as against Rs 380.23 crore during the previous quarter ended December 2024. Sales rose 11.52% to Rs 3567.20 crore in the quarter ended December 2025 as against Rs 3198.79 crore during the previous quarter ended December 2024.
| Particulars | Quarter Ended |
| Dec. 2025 | Dec. 2024 | % Var. |
| Sales | 3567.20 | 3198.79 | 12 |
| OPM % | 25.77 | 25.51 | - |
| PBDT | 838.19 | 675.50 | 24 |
| PBT | 615.59 | 488.33 | 26 |
| NP | 408.75 | 380.23 | 8 |